دورية أكاديمية

Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial

التفاصيل البيبلوغرافية
العنوان: Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial
المؤلفون: DE SANCTIS, RITA, Bertuzzi, Alexia, Basso, Umberto, Comandone, Alessandro, Marchetti, Silvia, Marrari, Andrea, Colombo, Piergiuseppe, Lutman, Romano Fabio, Giordano, Laura, Santoro, Armando
المساهمون: DE SANCTIS, Rita, Bertuzzi, Alexia, Basso, Umberto, Comandone, Alessandro, Marchetti, Silvia, Marrari, Andrea, Colombo, Piergiuseppe, Lutman, Romano Fabio, Giordano, Laura, Santoro, Armando
بيانات النشر: International Institute of Anticancer Research
سنة النشر: 2015
المجموعة: Sapienza Università di Roma: CINECA IRIS
مصطلحات موضوعية: non-pegylated liposomal doxorubicin, phase II, soft tissue sarcoma
الوصف: Non-pegylated liposomal doxorubicin (NPLD) has demonstrated antitumour activity equivalent to conventional doxorubicin and a significantly lower risk of cardiotoxicity. This phase II trial was performed to evaluate the activity and the safety of NPLD and ifosfamide combination in patients with metastatic soft tissue sarcoma.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25550600; info:eu-repo/semantics/altIdentifier/wos/WOS:000347735300073; volume:35; issue:1; firstpage:543; lastpage:548; numberofpages:6; journal:ANTICANCER RESEARCH; http://hdl.handle.net/11573/872674Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84920505087
الإتاحة: http://hdl.handle.net/11573/872674Test
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.27D19C95
قاعدة البيانات: BASE